FI863971A0 - Farmaceutisk komposition anvaendbar vid behandling av leukopenia. - Google Patents

Farmaceutisk komposition anvaendbar vid behandling av leukopenia.

Info

Publication number
FI863971A0
FI863971A0 FI863971A FI863971A FI863971A0 FI 863971 A0 FI863971 A0 FI 863971A0 FI 863971 A FI863971 A FI 863971A FI 863971 A FI863971 A FI 863971A FI 863971 A0 FI863971 A0 FI 863971A0
Authority
FI
Finland
Prior art keywords
human
leukopenia
csf
behindling
pharmaceutical composition
Prior art date
Application number
FI863971A
Other languages
English (en)
Other versions
FI863971A (fi
Inventor
Masahiko Tamura
Hitoshi Nomura
Kunihiro Hattori
Masayoshi Ono
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26462024&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI863971(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FI863971A0 publication Critical patent/FI863971A0/fi
Publication of FI863971A publication Critical patent/FI863971A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI863971A 1985-10-04 1986-10-01 Farmaceutisk komposition anvaendbar vid behandling av leukopenia. FI863971A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22045085 1985-10-04
JP61125660A JPH0618778B2 (ja) 1985-10-04 1986-06-02 白血球減少症治療剤

Publications (2)

Publication Number Publication Date
FI863971A0 true FI863971A0 (fi) 1986-10-01
FI863971A FI863971A (fi) 1987-04-05

Family

ID=26462024

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863971A FI863971A (fi) 1985-10-04 1986-10-01 Farmaceutisk komposition anvaendbar vid behandling av leukopenia.

Country Status (11)

Country Link
EP (1) EP0217404B2 (fi)
JP (1) JPH0618778B2 (fi)
KR (1) KR960000394B1 (fi)
AT (1) ATE71662T1 (fi)
AU (1) AU596997C (fi)
DE (1) DE3683430D1 (fi)
DK (1) DK172204B1 (fi)
ES (1) ES2055684T5 (fi)
FI (1) FI863971A (fi)
HK (1) HK65693A (fi)
NO (1) NO863918L (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112175906A (zh) * 2019-07-05 2021-01-05 中国科学院生物物理研究所 胸腺嘧啶核苷诱导成纤维细胞转分化在中性粒细胞减少症治疗中的应用

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3686582T2 (de) * 1985-11-27 1993-01-28 Genetics Inst Behandlung einer krankheit vom aids-typ.
JPH0618779B2 (ja) * 1986-01-22 1994-03-16 中外製薬株式会社 造血機能回復促進剤
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
CA1329119C (en) * 1988-03-29 1994-05-03 Milton David Goldenberg Cytotoxic therapy
EP0455726A1 (en) * 1989-01-30 1991-11-13 Schering Corporation Treatment of leukocyte dysfunction with gm-csf
EP0565722A1 (en) * 1990-12-25 1993-10-20 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical preparation for pernasal administration
US5686578A (en) 1994-08-05 1997-11-11 Immunomedics, Inc. Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
EP1997829A1 (en) 2001-12-21 2008-12-03 Human Genome Sciences, Inc. Albumin fusion proteins
SI21273A (sl) * 2002-07-31 2004-02-29 LEK farmacevtska dru�ba d.d. Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina
EP2426139B1 (en) 2002-08-27 2014-10-01 Biokine Therapeutics Ltd. CXCR4 antagonist and use thereof
KR100638453B1 (ko) * 2004-11-19 2006-10-24 씨제이 주식회사 포장용 박스 및 포장용 박스 접는방법
US8663651B2 (en) 2006-12-21 2014-03-04 Biokine Therapeutics Ltd. T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation
WO2010092571A2 (en) 2009-02-11 2010-08-19 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
MX2011013459A (es) 2009-06-14 2012-05-08 Biokine Therapeutics Ltd Terapia de peptido para incrementar los niveles de plaquetas.
EP2841084B1 (en) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
EP3744340A3 (en) 2015-07-16 2021-03-03 Biokine Therapeutics Ltd. Compositions and methods for treating cancer
KR102033920B1 (ko) 2016-02-23 2019-10-18 바이오라인알엑스 리미티드 급성 골수성 백혈병을 치료하는 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6030295B2 (ja) * 1977-03-29 1985-07-16 森永乳業株式会社 白血球減少症治療剤の製造法
SE451844B (sv) * 1978-03-20 1987-11-02 Morinaga Milk Industry Co Ltd Glykoprotein, forfarande for framstellning derav samt terapeutiskt medel innehallande nemnda glykoprotein
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
JPS5618591A (en) * 1979-07-20 1981-02-21 Morinaga Milk Ind Co Ltd Production of substance capable of differentiation and multiplication of stem cells of human granulocyte
JPS6030654B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒトコロニ−刺激因子の製造方法
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
JPS6181781A (ja) * 1984-09-28 1986-04-25 Morinaga Milk Ind Co Ltd 人顆粒球系前駆細胞の分化・増殖因子産生細胞および人顆粒球系前駆細胞の分化・増殖因子の製造法
AU608741B2 (en) * 1984-11-20 1991-04-18 Schering Biotech Corporation cDNA clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity
WO1986004587A1 (en) * 1985-02-05 1986-08-14 Cetus Corporation Purification of native colony stimulating factor-1
JPH0615477B2 (ja) * 1985-02-08 1994-03-02 中外製薬株式会社 感染防禦剤
DE3680613D1 (de) * 1985-02-08 1991-09-05 Chugai Pharmaceutical Co Ltd Menschlicher granuloxcyt-kolonie-stimulierungsfaktor.
JPS63500636A (ja) * 1985-08-23 1988-03-10 麒麟麦酒株式会社 多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
DE3681551D1 (de) * 1985-09-30 1991-10-24 Chugai Pharmaceutical Co Ltd Menschlicher granulozyten-colony stimulierender faktor.
JPS6444200A (en) * 1987-08-12 1989-02-16 Kenji Hoshino Stereophonic sound field recording and reproducing system
JPH0615477A (ja) * 1992-07-02 1994-01-25 Tanaka Kikinzoku Kogyo Kk Ａｇろう

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112175906A (zh) * 2019-07-05 2021-01-05 中国科学院生物物理研究所 胸腺嘧啶核苷诱导成纤维细胞转分化在中性粒细胞减少症治疗中的应用
CN112175906B (zh) * 2019-07-05 2023-09-29 中国科学院生物物理研究所 胸腺嘧啶核苷诱导成纤维细胞转分化在中性粒细胞减少症治疗中的应用

Also Published As

Publication number Publication date
JPS62174026A (ja) 1987-07-30
EP0217404A2 (en) 1987-04-08
NO863918L (no) 1987-04-06
KR870003792A (ko) 1987-05-04
FI863971A (fi) 1987-04-05
AU596997B2 (en) 1990-05-24
AU596997C (en) 1993-01-21
ES2055684T5 (es) 1999-06-16
DE3683430D1 (de) 1992-02-27
ATE71662T1 (de) 1992-02-15
JPH0618778B2 (ja) 1994-03-16
ES2055684T3 (es) 1994-09-01
DK471386A (da) 1987-04-05
EP0217404B2 (en) 1999-01-07
EP0217404B1 (en) 1992-01-15
NO863918D0 (no) 1986-10-02
DK471386D0 (da) 1986-10-02
HK65693A (en) 1993-07-16
EP0217404A3 (en) 1988-07-13
KR960000394B1 (ko) 1996-01-06
DK172204B1 (da) 1998-01-05
AU6312186A (en) 1987-04-09

Similar Documents

Publication Publication Date Title
FI863971A (fi) Farmaceutisk komposition anvaendbar vid behandling av leukopenia.
LV12642A (lv) G csf analog compositions and methods
ATE65798T1 (de) Menschlicher granuloxcyt-koloniestimulierungsfaktor.
ATE348883T1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
NZ218332A (en) Il-4(interleukin-4), recombinant production, dna, vectors and pharmaceutical composition
IL77369A (en) Alpha, beta or omega horse interferon, their preparation and pharmaceutical compositions containing them, recombinant dna coding therefor and transformed host organisms containing such dna
EP0230980A3 (en) Pharmaceutical agent for promoting the recovery of hemopoietic capacity
DE69007744D1 (de) Verwendung von Interleukin 2 zur Behandlung von Leukämien.
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
DK0494260T3 (da) Receptorer for granulocytkolonistimulerende faktor
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
ES2002164A6 (es) Un metodo para producir un polipeptido o una gicoproteina que tiene una actividad de factor estimulante de colonias de granulocitos humanos.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: CHUGAI SEIYAKU KABUSHIKI KAISHA